TRIB
Trinity Biotech
TRIB
TRIB
52 hedge funds and large institutions have $81.5M invested in Trinity Biotech in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $73K
Holders
52
Holding in Top 10
2
Calls
–
Puts
$73K
Top Buyers
| 1 | +$1M | |
| 2 | +$860K | |
| 3 | +$551K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$455K |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$454K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$1.06M | |
| 3 | -$973K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$884K |
| 5 |
CSC
Cove Street Capital
El Segundo,
California
|
-$607K |